F523-1226 Screening compound: 1-{1,4-dioxa-8-azaspiro[4.5]decan-8-yl}-2-{4-[1-(4-methylphenyl)-1H-pyrazol-4-yl]-1,2,3,6-tetrahydropyridin-1-yl}ethan-1-one

F523-1226 Screening compound: 1-{1,4-dioxa-8-azaspiro[4.5]decan-8-yl}-2-{4-[1-(4-methylphenyl)-1H-pyrazol-4-yl]-1,2,3,6-tetrahydropyridin-1-yl}ethan-1-one
F523-1226 Screening compound: 1-{1,4-dioxa-8-azaspiro[4.5]decan-8-yl}-2-{4-[1-(4-methylphenyl)-1H-pyrazol-4-yl]-1,2,3,6-tetrahydropyridin-1-yl}ethan-1-one alternative view

Chemical Structure Depiction of ChemDiv screening compound F523-1226
1-{1,4-dioxa-8-azaspiro[4.5]decan-8-yl}-2-{4-[1-(4-methylphenyl)-1H-pyrazol-4-yl]-1,2,3,6-tetrahydropyridin-1-yl}ethan-1-one

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

F523-1226

Molecular Formula

C24H30N4O3 (C24 H30 N4 O3)

Compound Name

1-{1,4-dioxa-8-azaspiro[4.5]decan-8-yl}-2-{4-[1-(4-methylphenyl)-1H-pyrazol-4-yl]-1,2,3,6-tetrahydropyridin-1-yl}ethan-1-one

IUPAC name

1-{14-dioxa-8-azaspiro[4.5]decan-8-yl}-2-{4-[1-(4-methylphenyl)-1H-pyrazol-4-yl]-1236-tetrahydropyridin-1-yl}ethan-1-one

SMILES

Cc(cc1)ccc1-n1ncc(C2=CCN(CC(N(CC3)CCC33OCCO3)=O)CC2)c1

InChI

InChI=1S/C24H30N4O3/c1-19-2-4-22(5-3-19)28-17-21(16-25-28)20-6-10-26(11-7-20)18-23(29)27-12-8-24(9-13-27)30-14-15-31-24/h2-6,16-17H,7-15,18H2,1H3

InChI Key

ZLQZVLLJQKNYCX-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD14957856

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

422.53

Hydrogen Bond Acceptors Count

6.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

5.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

2.339

Distribution Coefficient, logD

2.339

Water Solubility, LogSw

-2.48

Polar Surface Area

48.886

Acid Dissociation Constant (pKa)

24.66

Base Dissociation Constant (pKb)

4.04

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

50.00

F523-1226 in Drug Discovery

Included in Screening Libraries

DGK Inhibitors Library (10558 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Digestive system
  • Hemic and lymphatic
  • Skin
  • Metabolic
  • Immune system
Targets:
  • Kinases

References: we are preparing a list of scientific research reports with F523-1226 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound F523-1226?
Check Price and Availability of F523-1226, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of F523-1226 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for F523-1226
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for F523-1226
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of F523-1226 available by request